{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:36:21Z","timestamp":1788489381484,"version":"build-2803163510"},"reference-count":54,"publisher":"Radiation Research Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2019,7,10]]},"DOI":"10.1667\/rr15341.1","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T17:11:49Z","timestamp":1562778709000},"page":"299","source":"Crossref","is-referenced-by-count":40,"title":["Radiation and Risk of Liver, Biliary Tract, and Pancreatic Cancers among Atomic Bomb Survivors in Hiroshima and Nagasaki: 1958\u20132009"],"prefix":"10.1667","volume":"192","author":[{"given":"Atsuko","family":"Sadakane","sequence":"first","affiliation":[{"name":"Departments of Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"French","sequence":"additional","affiliation":[{"name":"Departments of Statistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina V.","family":"Brenner","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale L.","family":"Preston","sequence":"additional","affiliation":[{"name":"Departments of Hirosoft International Corporation, Eureka, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Grant","sequence":"additional","affiliation":[{"name":"Departments of Associate Chief of Research, Radiation Effects Research Foundation, Hiroshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritsu","family":"Sakata","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Utada","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K.","family":"Cahoon","sequence":"additional","affiliation":[{"name":"Departments of Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiko","family":"Mabuchi","sequence":"additional","affiliation":[{"name":"Departments of Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Ozasa","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1243","reference":[{"key":"16","doi-asserted-by":"crossref","unstructured":"DL Preston, E Ron, S Tokuoka, et al. \"Radiat Res.\" 168, \"Solid cancer incidence in atomic bomb survivors: 1958\u20131998.\" 1 (2007)","DOI":"10.1667\/RR0763.1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"K Ozasa, Y Shimizu, A Suyama, et al. \"Radiat Res.\" 177, \"Studies of the mortality of atomic bomb survivors, Report 14, 1950\u20132003: an overview of cancer and noncancer diseases.\" 229 (2012)","DOI":"10.1667\/RR2629.1"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Z Tao, S Akiba, Y Zha, et al. \"Health Phys.\" 102, \"Cancer and noncancer mortality among Inhabitants in the high background radiation area of Yangjiang, China (1979\u20131998).\" 173 (2012)","DOI":"10.1097\/HP.0b013e31822c7f1e"},{"key":"13","doi-asserted-by":"crossref","unstructured":"DL Preston, Y Shimizu, DA Pierce, et al. \"Radiat Res.\" 160, \"Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950\u20131997.\" 381 (2003)","DOI":"10.1667\/RR3049"},{"key":"1","doi-asserted-by":"crossref","unstructured":"F Bray, J Ferlay, I Soerjomataram, et al. \"CA Cancer J Clin.\" 68, \"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.\" 394 (2018)","DOI":"10.3322\/caac.21492"},{"key":"2","unstructured":"et al. \"Vital statistics Japan.\" , (2016)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"K Tanaka, T Hirohata, S Koga, et al. \"Cancer Res.\" 51, \"Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.\" 2842 (1991)","DOI":"10.1002\/ijc.2910510402"},{"key":"4","unstructured":"WT London, JL Petrick, K McGlynn, \"Cancer epidemiology and prevention.\" , \"Liver cancer.\" 635 (2018)"},{"key":"5","doi-asserted-by":"crossref","unstructured":"H. Yoshizawa, \"Oncology.\" 62, \"Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future.\" S8 (2002)","DOI":"10.1159\/000048270"},{"key":"6","doi-asserted-by":"crossref","unstructured":"H Tsukuma, T Hiyama, S Tanaka, et al. \"N Engl J Med.\" 328, \"Risk factors for hepatocellular carcinoma among patients with chronic liver disease.\" 1797 (1993)","DOI":"10.1056\/NEJM199306243282501"},{"key":"7","doi-asserted-by":"crossref","unstructured":"H Tanaka, Y Imai, N Hiramatsu, et al. \"Ann Intern Med.\" 148, \"Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003.\" 820 (2008)","DOI":"10.7326\/0003-4819-148-11-200806030-00004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"ME Sokolnikov, ES Gilbert, DL Preston, et al. \"Int J Cancer.\" 123, \"Lung, liver and bone cancer mortality in Mayak workers.\" 905 (2008)","DOI":"10.1002\/ijc.23581"},{"key":"9","doi-asserted-by":"crossref","unstructured":"T Mori, C Kido, K Fukutomi, et al. \"Radiat Res.\" 152, \"Summary of entire Japanese thorotrast follow-up study: updated 1998.\" S84 (1999)","DOI":"10.2307\/3580120"},{"key":"10","doi-asserted-by":"crossref","unstructured":"LB Travis, M Hauptmann, LK Gaul, et al. \"Radiat Res.\" 160, \"Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast.\" 691 (2003)","DOI":"10.1667\/RR3095"},{"key":"11","unstructured":"et al. \"Effects of ionizing radiation: United Nations Scientific Committee on the Effects of Atomic Radiation: UNSCEAR 2006 Report to the General Assembly, with scientific annexes.\" , (2008)"},{"key":"12","doi-asserted-by":"crossref","unstructured":"DB Richardson, E Cardis, RD Daniels, et al. \"Epidemiology.\" 29, \"Site-specific Solid Cancer Mortality After Exposure to Ionizing Radiation: A Cohort Study of Workers (INWORKS).\" 31 (2018)","DOI":"10.1097\/EDE.0000000000000761"},{"key":"15","doi-asserted-by":"crossref","unstructured":"DE Thompson, K Mabuchi, E Ron, et al. \"Radiat Res.\" 137, \"Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958\u20131987.\" S17 (1994)","DOI":"10.2307\/3578892"},{"key":"17","doi-asserted-by":"crossref","unstructured":"JB Cologne, S Tokuoka, GW Beebe, et al. \"Radiat Res.\" 152, \"Effects of radiation on incidence of primary liver cancer among atomic bomb survivors.\" 364 (1999)","DOI":"10.2307\/3580221"},{"key":"18","doi-asserted-by":"crossref","unstructured":"M Inoue, N Sawada, T Matsuda, et al. \"Ann Oncol.\" 23, \"Attributable causes of cancer in Japan in 2005\u2013systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan.\" 1362 (2012)","DOI":"10.1093\/annonc\/mdr437"},{"key":"19","doi-asserted-by":"crossref","unstructured":"GB Sharp, T Mizuno, JB Cologne, et al. \"Int J Cancer.\" 103, \"Hepatocellular carcinoma among atomic bomb survivors: significant interaction of radiation with hepatitis C virus infections.\" 531 (2003)","DOI":"10.1002\/ijc.10862"},{"key":"20","doi-asserted-by":"crossref","unstructured":"W Ohishi, S Fujiwara, JB Cologne, et al. \"Hepatology.\" 53, \"Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma.\" 1237 (2011)","DOI":"10.1002\/hep.24207"},{"key":"21","doi-asserted-by":"crossref","unstructured":"SO Antwi, RJ Jansen, GM Petersen, \"Cancer epidemiology and prevention.\" , \"Cancer of the pancreas.\" 611 (2018)","DOI":"10.1093\/oso\/9780190238667.003.0032"},{"key":"22","doi-asserted-by":"crossref","unstructured":"J Koshiol, C Ferreccio, SS Devesa, et al. \"Cancer epidemiology and prevention.\" , \"Biliary tract cancer.\" 661 (2018)","DOI":"10.1093\/oso\/9780190238667.003.0034"},{"key":"23","doi-asserted-by":"crossref","unstructured":"GM Dores, RE Curtis, FE van Leeuwen, et al. \"Ann Oncol.\" 25, \"Pancreatic cancer risk after treatment of Hodgkin lymphoma.\" 2073 (2014)","DOI":"10.1093\/annonc\/mdu287"},{"key":"24","doi-asserted-by":"crossref","unstructured":"M Hauptmann, T Borge Johannesen, ES Gilbert, et al. \"Br J Cancer.\" 115, \"Increased pancreatic cancer risk following radiotherapy for testicular cancer.\" 901 (2016)","DOI":"10.1038\/bjc.2016.272"},{"key":"26","doi-asserted-by":"crossref","unstructured":"EK Cahoon, DL Preston, DA Pierce, et al. \"Radiat Res.\" 187, \"Lung, laryngeal and other respiratory cancer incidence among Japanese atomic bomb survivors: An updated analysis from 1958 through 2009.\" 538 (2017)","DOI":"10.1667\/RR14583.1"},{"key":"27","doi-asserted-by":"crossref","unstructured":"AV Brenner, DL Preston, R Sakata, et al. \"Radiat Res.\" 190, \"Incidence of breast cancer in the Life Span Study of atomic bomb survivors: 1958\u20132009.\" 433 (2018)","DOI":"10.1667\/RR15015.1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"M Utada, AV Brenner, DL Preston, et al. \"JNCI Cancer Spectrum.\" 2, \"Radiation risks of uterine cancer in atomic bomb survivors: 1958\u20132009.\" 1 (2019)","DOI":"10.1093\/jncics\/pky081"},{"key":"29","doi-asserted-by":"crossref","unstructured":"H Sugiyama, M Misumi, A Brenner, et al. \"Int J Cancer.\" , \"Radiation risk of incident colorectal cancer by anatomical site among atomic bomb survivors: 1958\u20132009.\" (2019)","DOI":"10.1002\/ijc.32275"},{"key":"32","doi-asserted-by":"crossref","unstructured":"DA Pierce, DO Stram, M Vaeth, \"Radiat Res.\" 123, \"Allowing for random errors in radiation dose estimates for the atomic bomb survivor data.\" 275 (1990)","DOI":"10.2307\/3577733"},{"key":"34","doi-asserted-by":"crossref","unstructured":"B French, J Cologne, R Sakata, et al. \"Eur J Epidemiol.\" 32, \"Selection of reference groups in the Life Span Study of atomic bomb survivors.\" 1055 (2017)","DOI":"10.1007\/s10654-017-0337-9"},{"key":"35","doi-asserted-by":"crossref","unstructured":"WC Palmer and T Patel \"J Hepatol.\" 57, \"Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.\" 69 (2012)","DOI":"10.1016\/j.jhep.2012.02.022"},{"key":"36","doi-asserted-by":"crossref","unstructured":"S Ishiguro, M Inoue, N Kurahashi, et al. \"Cancer Causes Control.\" 19, \"Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification.\" 33 (2008)","DOI":"10.1007\/s10552-007-9067-8"},{"key":"37","doi-asserted-by":"crossref","unstructured":"TM Welzel, BI Graubard, HB El-Serag, et al. \"Clin Gastroenterol Hepatol.\" 5, \"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.\" 1221 (2007)","DOI":"10.1016\/j.cgh.2007.05.020"},{"key":"38","doi-asserted-by":"crossref","unstructured":"DA Pierce and DL Preston \"Radiat Res.\" 134, \"Joint analysis of site-specific cancer risks for the atomic bomb survivors.\" 134 (1993)","DOI":"10.2307\/3578452"},{"key":"39","doi-asserted-by":"crossref","unstructured":"S Fujiwara, S Kusumi, J Cologne, et al. \"Radiat Res.\" 154, \"Prevalence of anti-hepatitis C virus antibody and chronic liver disease among atomic bomb survivors.\" 12 (2000)","DOI":"10.1667\/0033-7587(2000)154[0012:POAHCV]2.0.CO;2"},{"key":"40","doi-asserted-by":"crossref","unstructured":"SC Darby, R Doll, SK Gill, et al. \"Br J Cancer.\" 55, \"Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis.\" 179 (1987)","DOI":"10.1038\/bjc.1987.35"},{"key":"41","doi-asserted-by":"crossref","unstructured":"ZA Carr, RA Kleinerman, M Stovall, et al. \"Radiat Res.\" 157, \"Malignant neoplasms after radiation therapy for peptic ulcer.\" 668 (2002)","DOI":"10.1667\/0033-7587(2002)157[0668:MNARTF]2.0.CO;2"},{"key":"42","doi-asserted-by":"crossref","unstructured":"E Cardis, ES Gilbert, L Carpenter, et al. \"Radiat Res.\" 142, \"Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries.\" 117 (1995)","DOI":"10.2307\/3579020"},{"key":"43","doi-asserted-by":"crossref","unstructured":"JX Wang, LA Zhang, BX Li, et al. \"Health Phys.\" 82, \"Cancer incidence and risk estimation among medical x-ray workers in China, 1950-1995.\" 455 (2002)","DOI":"10.1097\/00004032-200204000-00004"},{"key":"45","doi-asserted-by":"crossref","unstructured":"ES Gilbert, NA Koshurnikova, M Sokolnikov, et al. \"Radiat Res.\" 154, \"Liver cancers in Mayak workers.\" 246 (2000)","DOI":"10.1667\/0033-7587(2000)154[0246:LCIMW]2.0.CO;2"},{"key":"46","doi-asserted-by":"crossref","unstructured":"EV Labutina, IS Kuznetsova, N Hunter, et al. \"Health Phys.\" 105, \"Radiation risk of malignant neoplasms in organs of main deposition for plutonium in the cohort of Mayak workers with regard to histological types.\" 165 (2013)","DOI":"10.1097\/HP.0b013e31828f57df"},{"key":"47","doi-asserted-by":"crossref","unstructured":"GE Dagle, EP Moen, RR Adee, et al. \"Health Phys.\" 63, \"Microdistribution and microdosimetry of thorium deposited in the liver.\" 41 (1992)","DOI":"10.1097\/00004032-199207000-00006"},{"key":"48","doi-asserted-by":"crossref","unstructured":"PD Inskip, RR Monson, JK Wagoner, et al. \"Radiat Res.\" 123, \"Cancer mortality following radium treatment for uterine bleeding.\" 331 (1990)","DOI":"10.2307\/3577741"},{"key":"49","unstructured":"JD Boice, G Engholm, RA Kleinerman, et al. \"Radiat Res.\" 116, \"Radiation dose and second cancer risk in patients treated for cancer of the cervix.\" 3 (1988)"},{"key":"50","doi-asserted-by":"crossref","unstructured":"HA Weiss, SC Darby, R Doll, \"Int J Cancer.\" 59, \"Cancer mortality following X-ray treatment for ankylosing spondylitis.\" 327 (1994)","DOI":"10.1002\/ijc.2910590307"},{"key":"51","doi-asserted-by":"crossref","unstructured":"H Kato, M Mayumi, K Nishioka, et al. \"Am J Epidemiol.\" 117, \"The relationship of hepatitis B surface antigen and antibody to atomic bomb radiation in the Adult Health Study sample, 1975\u20131977.\" 610 (1983)","DOI":"10.1093\/oxfordjournals.aje.a113584"},{"key":"52","doi-asserted-by":"crossref","unstructured":"K Neriishi, S Akiba, T Amano, et al. \"Radiat Res.\" 144, \"Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors.\" 215 (1995)","DOI":"10.2307\/3579261"},{"key":"53","doi-asserted-by":"crossref","unstructured":"S Fujiwara, GB Sharp, JB Cologne, et al. \"Radiat Res.\" 159, \"Prevalence of hepatitis B virus infection among atomic bomb survivors.\" 780 (2003)","DOI":"10.1667\/0033-7587(2003)159[0780:POHBVI]2.0.CO;2"},{"key":"54","doi-asserted-by":"crossref","unstructured":"GB Sharp, JB Cologne, T Fukuhara, et al. \"Int J Cancer.\" 93, \"Temporal changes in liver cancer incidence rates in Japan: accounting for death certificate inaccuracies and improving diagnostic techniques.\" 751 (2001)","DOI":"10.1002\/ijc.1390"},{"key":"30","doi-asserted-by":"crossref","unstructured":"HM Cullings, S Fujita, S Funamoto, et al. \"Radiat Res.\" 166, \"Dose estimation for atomic bomb survivor studies: its evolution and present status.\" 219 (2006)","DOI":"10.1667\/RR3546.1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"EJ Grant, A Brenner, H Sugiyama, et al. \"Radiat Res.\" 187, \"Solid cancer incidence among the Life Span Study of Atomic Bomb Survivors: 1958\u20132009.\" 513 (2017)","DOI":"10.1667\/RR14492.1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"HM Cullings, EJ Grant, SD Egbert, et al. \"Health Phys.\" 112, \"DS02R1: Improvements to atomic bomb survivors' input data and implementation of Dosimetry System 2002 (DS02) and resulting changes in estimated doses.\" 56 (2017)","DOI":"10.1097\/HP.0000000000000598"},{"key":"33","doi-asserted-by":"crossref","unstructured":"R Sakata, P McGale, EJ Grant, et al. \"BMJ.\" 345, \"Impact of smoking on mortality and life expectancy in Japanese smokers: a prospective cohort study.\" e7093 (2012)","DOI":"10.1136\/bmj.e7093"}],"container-title":["Radiation Research"],"original-title":[],"deposited":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T10:05:56Z","timestamp":1610359556000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-192\/issue-3\/RR15341.1\/Radiation-and-Risk-of-Liver-Biliary-Tract-and-Pancreatic-Cancers\/10.1667\/RR15341.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1667\/rr15341.1","relation":{},"ISSN":["0033-7587"],"issn-type":[{"value":"0033-7587","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,10]]}}}